MedPath

Effect of intraperitoneal and intravenous dexamethasone in reduce pain and nausea and vomiting after laparoscopic surgery

Phase 2
Recruiting
Conditions
aparoscopic surgical.
Laparoscopic surgical procedure converted to open procedure
Z53.31
Registration Number
IRCT20160523028008N18
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

Ages between 18 and 60 years
Patients who need laparoscopic surgery due to a gynecological indication

Exclusion Criteria

History of abdominal surgery
Extensive pelvic surgeries
Body mass index(BMI) of more than 40
Existence of diseases of the stomach and intestines
Drug allergy to dexamethasone

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of nausea. Timepoint: 6, 12, 18 and 24 hours after surgery. Method of measurement: Visual Analogue Scale (VAS).;Severity of vomiting. Timepoint: 6, 12, 18 and 24 hours after surgery. Method of measurement: Visual Analogue Scale (VAS).;Severity of pain. Timepoint: 6, 12, 18 and 24 hours after surgery. Method of measurement: Visual Analogue Scale (VAS).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath